BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8104094)

  • 1. Rare HRAS1 alleles outside the VTR region in lymph nodes from patients with malignant lymphoma.
    Stul M; Baens M; Mecucci C; Van den Berghe H; Cassiman JJ
    Cancer Genet Cytogenet; 1993 Aug; 69(1):60-4. PubMed ID: 8104094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new RFLP in intron 1 of the human c-Ha-ras1 gene and its close relationship with the variable tandem repeats in the region 3' to the gene.
    Iwahana H; Orita M; Kanazawa H; Hayashi K; Sekiya T
    Oncogene; 1990 Jul; 5(7):1049-53. PubMed ID: 1973828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minisatellite allele diversification: the origin of rare alleles at the HRAS1 locus.
    Kasperczyk A; DiMartino NA; Krontiris TG
    Am J Hum Genet; 1990 Nov; 47(5):854-9. PubMed ID: 2220825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of two TaqI polymorphisms in the VTR region of the human HRAS1 oncogene.
    Pierotti MA; Radice P; Biunno I; Borrello MG; Cattadori MR; Della Porta G
    Cytogenet Cell Genet; 1986; 43(3-4):174-80. PubMed ID: 2879707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of allelic heterozygosity at the harvey ras locus in human oral carcinomas.
    Saranath D; Bhoite LT; Mehta AR; Sanghavi V; Deo MG
    J Cancer Res Clin Oncol; 1991; 117(5):484-8. PubMed ID: 1679760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele-specific deletion in exon I of the HRAS1 gene.
    Kasperczyk A; Mermer BA; Parkinson DR; Lonergan JA; Krontiris TG
    Am J Hum Genet; 1989 Nov; 45(5):689-96. PubMed ID: 2573274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of rare Ha-ras alleles: relationship of VTR length to a 5' polymorphic Xho I site.
    Baxter GD; Hayward NK; Collins RJ; Lavin MF
    Genet Res; 1989 Oct; 54(2):149-53. PubMed ID: 2558964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele.
    Wong WW; Cahill JM; Rosen MD; Kennedy CA; Bonaccio ET; Morris MJ; Wilson JG; Klickstein LB; Fearon DT
    J Exp Med; 1989 Mar; 169(3):847-63. PubMed ID: 2564414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HRAS1 proto-oncogene polymorphisms in human malignant melanoma: TaqI defined alleles significantly associated with the disease.
    Radice P; Pierotti MA; Borrello MG; Illeni MT; Rovini D; Della Porta G
    Oncogene; 1987; 2(1):91-5. PubMed ID: 2894003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide sequence of the 1.2-kb 3'-region and genotype distribution of two common c-myc alleles of the domestic cat.
    Soe LH; Ghosh AK; Maxson RE; Hoover EA; Hardy WD; Roy-Burman P
    Gene; 1986; 47(2-3):185-92. PubMed ID: 3557122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.
    Krontiris TG; Devlin B; Karp DD; Robert NJ; Risch N
    N Engl J Med; 1993 Aug; 329(8):517-23. PubMed ID: 8336750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients.
    Rosell R; Calvo R; Sánchez JJ; Maurel J; Guillot M; Monzó M; Núñez L; Barnadas A
    Clin Cancer Res; 1999 Jul; 5(7):1849-54. PubMed ID: 10430091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
    Phelan CM; Rebbeck TR; Weber BL; Devilee P; Ruttledge MH; Lynch HT; Lenoir GM; Stratton MR; Easton DF; Ponder BA; Cannon-Albright L; Larsson C; Goldgar DE; Narod SA
    Nat Genet; 1996 Mar; 12(3):309-11. PubMed ID: 8589723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare HRAS1 alleles are a risk factor for the development of brain tumors.
    Vega A; Sobrido MJ; Ruiz-Ponte C; Barros F; Carracedo A
    Cancer; 2001 Dec; 92(11):2920-6. PubMed ID: 11753967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the c-Ha-ras-1 locus polymorphism in an Italian population with high incidence of gastric cancer.
    Ranzani GN; Salerno-Mele P; Maltoni M; Talarico D; Della Valle G; Amadori D
    Mol Biol Med; 1988 Dec; 5(3):145-53. PubMed ID: 2907601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic variation of reporter gene activation by the HRAS1 minisatellite.
    Green M; Krontiris TG
    Genomics; 1993 Aug; 17(2):429-34. PubMed ID: 8406494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Length and sequence variation in D7S22 (g3) alleles studied by high resolution length measurements and nucleotide sequencing.
    Andreassen R; Olaisen B
    Electrophoresis; 1997 May; 18(5):675-81. PubMed ID: 9194589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human hypervariable sequences in risk assessment: rare Ha-ras alleles in cancer patients.
    Krontiris TG; DiMartino NA; Mitcheson HD; Lonergan JA; Begg C; Parkinson DR
    Environ Health Perspect; 1987 Dec; 76():147-53. PubMed ID: 3329095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Restriction polymorphism of the proto-oncogene c-Ha-ras-1 in patients with multiple primary malignant neoplasms and non-small-cell lung cancer].
    Gaspar'ian AV; Sel'chuk VIu; Iakubovskaia MG; Zborovskaia IB; Tatosian AG
    Genetika; 1997 Jan; 33(1):96-100. PubMed ID: 9162692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human restriction fragment length polymorphisms and cancer risk assessment.
    Krontiris TG; DiMartino NA; Colb M; Mitcheson HD; Parkinson DR
    J Cell Biochem; 1986; 30(4):319-29. PubMed ID: 3011817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.